InvestorsHub Logo
icon url

The Danish Dude

12/14/23 8:34 AM

#655757 RE: iclight #655750

Bullish
Bullish
icon url

learningcurve2020

12/14/23 9:08 AM

#655770 RE: iclight #655750

Would not surprise me either. Ever notice how the important questions asked here are nearly completely ignored? Those are the red flags.
icon url

ilovetech

12/14/23 9:14 AM

#655771 RE: iclight #655750

Brad had just become a lawyer and he was an accomplished, I'm not certain, if he was professional, or at least at a high level Water Polo athlete. It's during the height of his physical prime age, that he came down with GBM. It was early 20's, if I recall correctly. He's passed the 15 year mark.
icon url

j e d

12/14/23 10:46 AM

#655822 RE: iclight #655750

The median age was 56, which is the exact same as the Stupp trial. You can find this in Table 1 of Jama or JTM articles, and Table 1 of Stupp's NEJM article.
icon url

Lykiri

12/14/23 1:29 PM

#655902 RE: iclight #655750

I'll bet the 40-50 year old age group was greatly represented in the DCVax trial.



Wrong.

50 patients Age > 65 (JAMA – between 65 and 73 years old)
25% patients Age < 50 ( approximately 60 patients ; cfr. Phacilitate Conference)
The majority of the DCVax-L patients are between 50 and 65 years old; approximately 122 patients.

Note: only 6 patients are Age > 65 years in the DCVax-L placebo group (n= 99) (Phacilitate Conference)